pembrolizumab
merck
['pembro']
#keynote522 efs by rcb #asco22 pcr (rcb0) 94.7 vs 92.6%
rcb1 84.4 pbo vs pembro 83.8%
rcb2 75.7 pembro vs 55.9% pbo rcb3 34.6 pbo vs 26.2% pembro this data will help inform statistical design in future trials &amp; help guide prognostication for patients in clinic 
Director Breast Oncology, Lifespan Cancer Institute, Legorreta Cancer Center Brown Univ | Medical Advisor @drloveresearch | #bcsm #clinicaltrials | Views Mine